ABX advanced biochemical compounds GmbH

2 in Phase 3

Quick facts

Phase 3 pipeline

F-18-Fluorocholine · Oncology
F-18-Fluorocholine is a positron emission tomography (PET) imaging agent that accumulates in cells with high choline metabolism, enabling visualization of metabolically active tissues.
F-18-PSMA-1007 · Oncology
F-18-PSMA-1007 is a fluorine-18 labeled small molecule that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about ABX advanced biochemical compounds GmbH

What is ABX advanced biochemical compounds GmbH's pipeline?

ABX advanced biochemical compounds GmbH has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include F-18-Fluorocholine, F-18-PSMA-1007.

Sector hub: All tracked pharma companies